VaxEquity
Business Services · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.vaxequity.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About VaxEquity
VaxEquity is a UK biotechnology company specializing in the development of next-generation self-amplifying RNA (saRNA) therapeutics and vaccines. Their proprietary RNA platform is designed to enhance the innate immune response, facilitating higher and prolonged protein expression with lower doses. This innovation aims to address unmet medical needs and expand the potential applications of RNA in both therapeutics and vaccines. They seek to attract ambitious individuals to join their team in this pioneering science field.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is VaxEquity your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if VaxEquity is spiking on competitors!
Check if VaxEquity has recently received funding, and reach out quickly before it becomes old news!
Click to see if VaxEquity had a recent Job posting/layoffs
Earning: See what the market has to say on VaxEquity recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
VaxEquity, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once VaxEquity has new funding data
Product Launch: Get notified when VaxEquity launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at VaxEquity
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to VaxEquity
Compare insights from companies similar to VaxEquity, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
VaxEquity
<$5M
11-50
Private
-
2020
N/A
Company Profile Activity
Activity Insights
VaxEquity is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
VaxEquity is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about VaxEquity.
VaxEquity Tech Stack
A closer look at the technologies used by VaxEquity
VaxEquity News & Media
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding VaxEquity
Sign Up For FreeTo access detailed company insights
VaxEquity is a UK biotechnology company specializing in the development of next-generation self-amplifying RNA (saRNA) therapeutics and vaccines. Their proprietary RNA platform is designed to enhance the innate immune response, facilitating higher and prolonged protein expression with lower doses. This innovation aims to address unmet medical needs... Read More
